Rivaroxaban in non valvular atrial fibrillation: subgroups analysis
After the ROCKET AF study main paper several subgroups analysis were recently published. These studies are useful to better evaluate the rivaroxaban efficacy and safety in different clinical conditions. Here the subgroup analysis of patients with moderate renal failure, heart failure and diabetes ar...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2015-08-01
|
Series: | Monaldi Archives for Chest Disease |
Subjects: | |
Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/37 |